PATENT CLAIM ANALYSIS

Application Number: 15750282
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-04
Patent Classification: ["424", "009100"]

Abstract:
A composition in the form of a water-in-oil emulsion comprising: from 20% to 40% (v/v) of aqueous phase, in the form of droplets, comprising an anti-cancer agent and a densifying agent chosen from the complexes of nonionic macrocyclic chelate with a paramagnetic metal, from 60% to 80% (v/v) of lipid phase comprising an iodized oil and at least one surfactant of formula (I) in a proportion, by weight of surfactant relative to the total volume of the composition, of 0.3% to 5%, formula (I) of said surfactant being the following:   in which:  s is 0 or 1, m is an integer from 2 to 30, R 1  represents a group of formula (II)   in which n is an integer from 4 to 10, o is an integer from 1 to 4, p is an integer from 3 to 7, q is an integer from 2 to 10, and r is 0 or 1, R 2  represents a hydrogen atom or is identical to R 1 , and each R 3  independently represents a hydrogen atom or is identical to R 1 .

Claim (Index 19):
The composition of  claim 16 , wherein the anti-cancer agent is selected from the group consisting of anthracyclines, platinum complexes, mitoxantrone, nemorubicin, mitomycin C, bleomycin, actinomycin D, irinotecan, 5-fluorouracil, sorafenib, sunitinib, regorafenib, brivanib, orantinib, linsitinib, erlotinib, cabozantinib, foretinib, tivantinib, fotemustine, tauromustine (TCNU), carmustine, cytosine C, cyclophosphonamide, cytosine arabinoside, paclitaxel, docetaxel, methotrexate, everolimus, PEG-arginine deiminase, a tegafur/gimeracil/oteracil combination, muparfostat, peretinoin, gemcitabine, bevacizumab and ramucirumab, floxuridine, GM-CSF, molgramostim, sargramostim, OK-432, interleukin-2, interleukin-4 and TNFalpha,  125 I-labeled anti-CEA (carcinoembryonic antigen) antibodies, microspheres loaded with one of the foregoing, radioelements and complexes of said radioelements with macrocyclic chelates, magnetic particles based on an iron compound and/or on a gadolinium chelate, radioactive microspheres, deoxyribonucleic acid sequences, ribonucleic acid sequences, and combinations thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 2.45977
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14389432', '14349822', '10521669', '13580264', '13822514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7652882907290809
- 35 USC 102 Novelty (BERT): 0.4935462970456437
- Combined Prediction Score: 0.7381140913607372
- Mean Citation Score: 192.013748
- Max Citation Score: 220.46686
- Similarity Product: 152.4253842438555

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test